Vaccine effectiveness of Ad26.COV2.S against symptomatic COVID-19 and clinical outcomes in Brazil: a test-negative study design
Otavio T Ranzani, Rogério dos Santos Leite, Larissa Domingues Castilho, Crhistinne Cavalheiro Maymone Gonçalves, Geraldo Resende, Rosana Leite de Melo, Julio Croda
doi: https://doi.org/10.1101/2021.10.15.21265006
Otavio T Ranzani
1Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
2Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas (HCFMUSP), Faculdade de Medicina da Universidade de São Paulo, Brazil
PhDRogério dos Santos Leite
3Secretaria Municipal de Saúde de Corumbá, Corumbá, Brazil
MDLarissa Domingues Castilho
4Secretaria de Saúde do estado de Mato Grosso do Sul, Campo Grande, Brazil
PTCrhistinne Cavalheiro Maymone Gonçalves
4Secretaria de Saúde do estado de Mato Grosso do Sul, Campo Grande, Brazil
5Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil
PhDGeraldo Resende
4Secretaria de Saúde do estado de Mato Grosso do Sul, Campo Grande, Brazil
MDRosana Leite de Melo
6Secretaria Extraordinária de Enfrentamento à Covid-19, Ministério da Saúde, Brasília, Brazil
MDJulio Croda
5Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil
7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA
8Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil
PhDData Availability
Deidentified databases as well as the R codes will be deposited in the repository https://github.com/juliocroda/VebraCOVID-19
Posted October 18, 2021.
Vaccine effectiveness of Ad26.COV2.S against symptomatic COVID-19 and clinical outcomes in Brazil: a test-negative study design
Otavio T Ranzani, Rogério dos Santos Leite, Larissa Domingues Castilho, Crhistinne Cavalheiro Maymone Gonçalves, Geraldo Resende, Rosana Leite de Melo, Julio Croda
medRxiv 2021.10.15.21265006; doi: https://doi.org/10.1101/2021.10.15.21265006
Vaccine effectiveness of Ad26.COV2.S against symptomatic COVID-19 and clinical outcomes in Brazil: a test-negative study design
Otavio T Ranzani, Rogério dos Santos Leite, Larissa Domingues Castilho, Crhistinne Cavalheiro Maymone Gonçalves, Geraldo Resende, Rosana Leite de Melo, Julio Croda
medRxiv 2021.10.15.21265006; doi: https://doi.org/10.1101/2021.10.15.21265006
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2923)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12723)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4571)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2913)
- Health Policy (1069)
- Hematology (387)
- HIV/AIDS (924)
- Medical Education (423)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4341)
- Nursing (235)
- Nutrition (637)
- Oncology (2264)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6925)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (179)